Your browser doesn't support javascript.
loading
A new neurodevelopmental disorder linked to heterozygous variants in UNC79.
Bayat, Allan; Liu, Zhenjiang; Luo, Sheng; Fenger, Christina D; Højte, Anne F; Isidor, Bertrand; Cogne, Benjamin; Larson, Austin; Zanus, Caterina; Faletra, Flavio; Keren, Boris; Musante, Luciana; Gourfinkel-An, Isabelle; Perrine, Charles; Demily, Caroline; Lesca, Gaeton; Liao, Weiping; Ren, Dejian.
Affiliation
  • Bayat A; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. Electronic addres
  • Liu Z; Department of Biology, University of Pennsylvania, Philadelphia, PA; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
  • Luo S; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Fenger CD; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark; Amplexa Genetics A/S, Odense, Denmark.
  • Højte AF; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.
  • Isidor B; Department of Genetics, CHU Nantes, Nantes, France; University of Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
  • Cogne B; Department of Genetics, CHU Nantes, Nantes, France; University of Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
  • Larson A; University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.
  • Zanus C; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo," Trieste, Italy.
  • Faletra F; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo," Trieste, Italy.
  • Keren B; Department of Neurology, Epileptology Unit, Reference Center for Rare Epilepsies, Sorbonne University, La Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Musante L; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo," Trieste, Italy.
  • Gourfinkel-An I; Department of Neurology, Epileptology Unit, Reference Center for Rare Epilepsies, Sorbonne University, La Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Perrine C; Department of Medical Genetics, Pitié-Salpêtrière Hospital, AP-HP, University of Sorbonne, Paris, France.
  • Demily C; GénoPsy, Reference Center for Diagnosis and Management of Genetic Psychiatric Disorders, Vinatier Hospital Center and EDR-Psy Team (National Center for Scientific Research and Lyon 1 Claude Bernard University), Lyon, France; iMIND Excellence Center for Autism and Neurodevelopmental Disorders, Lyon,
  • Lesca G; Department of Medical Genetics, University Hospital of Lyon, Lyon, France.
  • Liao W; Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. Electronic address: wpliao@163.net.
  • Ren D; Department of Biology, University of Pennsylvania, Philadelphia, PA.
Genet Med ; 25(9): 100894, 2023 09.
Article in En | MEDLINE | ID: mdl-37183800
ABSTRACT

PURPOSE:

The "NALCN channelosome" is an ion channel complex that consists of multiple proteins, including NALCN, UNC79, UNC80, and FAM155A. Only a small number of individuals with a neurodevelopmental syndrome have been reported with disease causing variants in NALCN and UNC80. However, no pathogenic UNC79 variants have been reported, and in vivo function of UNC79 in humans is largely unknown.

METHODS:

We used international gene-matching efforts to identify patients harboring ultrarare heterozygous loss-of-function UNC79 variants and no other putative responsible genes. We used genetic manipulations in Drosophila and mice to test potential causal relationships between UNC79 variants and the pathology.

RESULTS:

We found 6 unrelated and affected patients with UNC79 variants. Five patients presented with overlapping neurodevelopmental features, including mild to moderate intellectual disability and a mild developmental delay, whereas a single patient reportedly had normal cognitive and motor development but was diagnosed with epilepsy and autistic features. All displayed behavioral issues and 4 patients had epilepsy. Drosophila with UNC79 knocked down displayed induced seizure-like phenotype. Mice with a heterozygous loss-of-function variant have a developmental delay in body weight compared with wild type. In addition, they have impaired ability in learning and memory.

CONCLUSION:

Our results demonstrate that heterozygous loss-of-function UNC79 variants are associated with neurologic pathologies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsy / Neurodevelopmental Disorders / Membrane Proteins / Intellectual Disability Limits: Animals / Humans Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsy / Neurodevelopmental Disorders / Membrane Proteins / Intellectual Disability Limits: Animals / Humans Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2023 Document type: Article